Abstract: Bardet-Biedl 
Introduction
In 1866, Laurence and Moon described a family of four siblings with retinal dystrophy, obesity, spastic paraparesis and cognitive deficit [1] . Bardet [2] and Biedl [3] later reported separately on further similarly affected individuals who in addition had post-axial polydactyly and the condition was coined Laurence-Moon-BardetBiedl syndrome. The syndrome is often divided into two entities: Laurence-Moon syndrome and Bardet-Biedl Syndrome (BBS), but there is considerable phenotypic overlap, suggesting that they may be allelic [4] . BBS is now the standard term in common usage. Mutations in at least 19 genes are known to cause Bardet-Biedl syndrome and inheritance is usually autosomal recessive ciliopathy secondary to the basal body dysfunction [5] . The frequency of the syndrome is estimated to be 1:1,60,000 [6] . Less than 15 cases have been reported from India [7] . The incidence is much higher in some populations with a high level of consanguinity or those that are geographically isolated, with disease incidence of 1 in 13,000 in the isolated populations of Newfoundland and Kuwait, 1 in 17,000 live births [8] . The characteristic combination of findings in BardetBiedl syndrome are rod cone dystrophy (93-100%), polydactyly (58-69%), obesity (72-88%), learning disabilities (41-62%), hypogenitalism in males (85-90%) and renal anomalies (25-100%) [9, 10] . BBS is distinguished from the much rarer Laurence-Moon syndrome, in which retinal pigmentary degeneration, mental retardation, and hypogonadism occur in conjunction with progressive spastic paraparesis and distal muscle weakness, but without polydactyly [11] . Treatment depends on the symptoms present in each person. Other features not always present include diabetes mellitus, neurological, speech and language deficits, hepatic fibrosis, behavioral traits, facial dysmorphism, dental anomalies and developmental delay. Recent research has demonstrated that some individuals with the Bardet-Biedl syndrome, if diagnosed early have responded well to disease management and rehabilitation; however very limited data is available.
II. Case report
A 28yrs old female patient admitted to the ward with complaints of loose motions, vague abdominal pain and generalized weakness since three days and decreased urine output since two days. She underwent serial of investigations in past for complaints of progressive weight gain and swelling all over her body. She also had history of progressive loss of vision with night blindness. There was no history of a preceding viral illness, joint swelling, palpitations and breathlessness. (Fig.1a,  Fig.1b ). She had developmental delay and was not able to learn adequately in school. No genital abnormalities were found in the patient. There was no past or family history of diabetes or thyroid disorder. On examination she was found to have pallor, obesity (Fig. 2) , a low volume pulse, low BP and bilateral lower limb edema. On systemic examination, heart sounds were normal, she had hepatomegaly. On neurological examination: hypotonia, broad based gait, poor coordination, balance, dysdiadochokinesia and past pointing were present without sensory disturbance. Speech was hypernasal and slow. The IQ was 74. Hearing assessment was normal. ECG was normal. Fundus examination showed bilateral optic atrophy, rod-cone dystrophy and grossly abnormal retinal function in both the eyes, suggestive of atypical retinitis pigmentosa (Fig. 3) . Complete blood counts with peripheral smear were suggestive of anemia with normocytic andhypochromic picture(Hb-6.0gm%,TLC-15060/cmm, MCV-84.9fL). renal function tests were deranged(BUN-37mg/dL, serum urea-79mg/dL, serum creatinine-3.49mg/dL, GFR-17 mL/min/m2), ESR-80mm at 1 hr. Laboratory tests including Iron studies(I151μg/dL, TIBC-176μg/dL, Sat-86%), vitamin B12 levels(>2000pg/mL), liver function(Total Bili-0.80mg/dL, SGOT-14U/L, SGPT-19U/L), serum sodium(135 mmol/L) and potassium(4.6 mmol/L), thyroid function(TSH-2.5μIU/ml, T3-70.95ng/dL, T4-7.6μg/dL), serum prolactin levels(28 ng/dL), ANA(negative), lipid profile tests(Chol-75mg/dL, TG-101mg/dL, HDL-20mg/dL) were found to be normal. bone marrow aspiration cytology study was normal. On ultrasonography there was hepatosplenomegaly with normal portal vein diameter and bilateral medical renal disease with mildly increased cortical echogenisity and preserved corticomedullary differentiation). There was no evidence of hepatic fibrosis in this case. 
III. Discussion
Bardet-Biedl syndrome is named after Georges Bardet and Arthur Biedl. It is usually diagnosed in childhood based upon thorough clinical evaluation and detection of characteristic findings (e.g., visual problems due to retinal dystrophy, obesity, polydactyly). In 1999, modified diagnostic criteria were defined after a study conducted in England in 109 BBS patients [12] . Patients who had 4 primary characteristics or 3 primary and 2 secondary criteria were identified as BBS (Table 1) . Genetic testing may assist in diagnosing the disorder in selected cases (e.g., individuals with certain BBS1 and BBS10 gene mutations. Investigators have determined 16 separate genes known to cause Bardet-Biedl syndrome (BBS1-BBS12), The most common defective gene associated with Bardet-Biedl syndrome is the BBS1 gene located on the long arm (q) of chromosome 11 (11q13). The gene products encoded by these BBS genes, called BBS proteins, are located in the basal body and cilia of the cell [13] . The most plausible hypothesis regarding a shared function for BBS proteins is that they assist microtubule-related transport and cellular organization processes, in particular relating to ciliary and centrosomal activities. This hypothesis is supported by several studies using different model organisms [14, 15, 16] . Some of the phenotypes exhibited by BBS proteins, including retinal degeneration, skeletal anomalies and renal cysts/malformations bear resemblance to human diseases associated with abnormal cilia function [17] . Recently it has been demonstrated that mutations in at least 19 genes cause Bardet-Biedl syndrome and inheritance is usually autosomal recessive ciliopathy secondary to the basal body dysfunction [5] . For clinical surveillance, initial investigation and follow up of BBS patients the recommended scheme is given in table 2. The treatment of Bardet-Biedl syndrome is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of Pediatricians, orthopedic surgeons, cardiologists, dental specialists, speech pathologists, audiologists, ophthalmologists, nephrologists, and other healthcare professionals. Individuals with Bardet-Biedl syndrome should undergo regular ophthalmologic examinations as well as periodic assessments to determine the presence of complications potentially associated with the disorder such as kidney dysfunction, diabete mellitus, liver function and high blood pressure. Early intervention is important in ensuring that children with Bardet-Biedl syndrome reach their highest potential. Genetic counselling may be of benefit for affected individuals and their families.
IV. Summary
Bardet-Biedl syndrome is a rare, genetic disorder with variable expressivity and a wide range of clinical variability. Main clinical features are cone-rod dystrophy, postaxial polydactyly, truncal obesity, kidney abnormalities and learning difficulties. Diagnosis is based on modified diagnostic criteria with 4 primary or 3 primary and 2 secondary features, along with genetic testing in selected cases. The treatment of Bardet-Biedl syndrome is directed toward the specific symptoms and may require the coordinated efforts of a team of specialists.
